[ Price : $8.95]
Former FDA chief counsel Dan Troy and assistant U.S. attorney Michael Loucks face off in discussion of policies and the law govern...[ Price : $8.95]
Federal Register Final rule: FDA approves a Cross Vetpharm Group supplemental NADA for a 100 mg/mL strength erythromycin injectabl...[ Price : $8.95]
Consulting editor John Scharmann reviews the Science Board report on FDA and finds its recommendations will require vast amounts o...[ Price : $8.95]
Cobalt Laboratories asks FDA to require in vivo bioequivalence studies for any ANDAs for a generic form of Bayers Precose.[ Price : $8.95]
Vidacare receives 510(k) clearance for the OnControl Bone Marrow Biopsy System.[ Price : $8.95]
An FDA advisory committee unanimously votes to recommend approval of Prestwick Pharmaceuticals tetrabenazine, indicated for treati...[ Price : $8.95]
FDA grants orphan drug status to Celldex Therapeutics CDX-110, indicated for treating EGFRvIII-expressing brain cancer.[ Price : $8.95]
FDAs Cardio-Renal Advisory Committee will consider recommendations for two drugs to treat atrial fibrillation.